This group explores all literacy and advocacy related to biomedical clinical trials. Conversations and events will range across the full spectrum of clinical trial life-cycles from pipeline development to post-trial planning.
Utilizing the local health system for the control arm
Such a good point Anne! I wonder what local health systems would see as some of the challenges. I imagine how data is aggregated and reported will have a big impact on using background incidence, but would be interested in hearing more from experts on this. And wonder if this was discussed during the recent Enterprise webinars (https://vaccineenterprise.org/hiv-prevention-clinical-trial-design-of-the-future/)